Global In-Vivo Toxicology Market Size, Share, Growth Analysis, Forecast 2034
In-Vivo Toxicology Market By Product Types (Instruments, Animal Models, and Reagents & Kits), By Testing Types (Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), By Toxicity Endpoints (Immunotoxicity, Systemic), By Testing Facility (Outsourced, In-House), By End-User (Academic Institutes, Research Institutes, and CRO’s), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034-
Category: Pharmaceutical Report Format : PDF
Pages: 222 Report Code: ZMR-965
Published Date: Apr-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 4.89 Billion | USD 8.48 Billion | 5.8% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global In-Vivo Toxicology Market, (2022 - 2028) (USD Billion)
- 2.2 Global In-Vivo Toxicology Market : snapshot
- Chapter 3. Global In-Vivo Toxicology Market - Industry Analysis
- 3.1 In-Vivo Toxicology Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Recent innovations in pharmaceutical and biotechnology industries along with rising focus on personalized medications to propel the market growth
- 3.3 Market Restraints
- 3.3.1. Availability of alternate methods of testing to animal testing and growing contempt against animal testing hampers the market growth
- 3.4 Market Opportunities
- 3.4.1. The increasing trend of humanized animal model testing in preclinical research provides a lucrative opportunity for market growth
- 3.5 Market Challenges
- 3.5.1. Government regulations against harming animals for medical testing pose a challenge for the market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Testing Types
- 3.7.3 Market attractiveness analysis By Toxicity Endpoints
- 3.7.4 Market attractiveness analysis By Testing facility
- 3.7.5 Market attractiveness analysis By End-user
- Chapter 4. Global In-Vivo Toxicology Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global In-Vivo Toxicology Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global In-Vivo Toxicology Market - Product Type Analysis
- 5.1 Global In-Vivo Toxicology Market overview: By Product Type
- 5.1.1 Global In-Vivo Toxicology Market share, By Product Type, 2021 and 2028
- 5.2 Instruments
- 5.2.1 Global In-Vivo Toxicology Market by Instruments, 2022 - 2028 (USD Billion)
- 5.3 Animal Models
- 5.3.1 Global In-Vivo Toxicology Market by Animal Models, 2022 - 2028 (USD Billion)
- 5.4 Reagents & Kits
- 5.4.1 Global In-Vivo Toxicology Market by Reagents & Kits, 2022 - 2028 (USD Billion)
- 5.1 Global In-Vivo Toxicology Market overview: By Product Type
- Chapter 6. Global In-Vivo Toxicology Market - Testing Types Analysis
- 6.1 Global In-Vivo Toxicology Market overview: By Testing Types
- 6.1.1 Global In-Vivo Toxicology Market share, By Testing Types, 2021 and 2028
- 6.2 Chronic Toxicity Testing
- 6.2.1 Global In-Vivo Toxicology Market by Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
- 6.3 Sub-Chronic Toxicity Testing
- 6.3.1 Global In-Vivo Toxicology Market by Sub-Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
- 6.4 Sub-acute Toxicity Testing
- 6.4.1 Global In-Vivo Toxicology Market by Sub-acute Toxicity Testing, 2022 - 2028 (USD Billion)
- 6.5 Acute Toxicity Testing
- 6.5.1 Global In-Vivo Toxicology Market by Acute Toxicity Testing, 2022 - 2028 (USD Billion)
- 6.1 Global In-Vivo Toxicology Market overview: By Testing Types
- Chapter 7. Global In-Vivo Toxicology Market - Toxicity Endpoints Analysis
- 7.1 Global In-Vivo Toxicology Market overview: By Toxicity Endpoints
- 7.1.1 Global In-Vivo Toxicology Market share, By Toxicity Endpoints, 2021 and 2028
- 7.2 Immunotoxicity
- 7.2.1 Global In-Vivo Toxicology Market by Immunotoxicity, 2022 - 2028 (USD Billion)
- 7.3 Systemic
- 7.3.1 Global In-Vivo Toxicology Market by Systemic, 2022 - 2028 (USD Billion)
- 7.1 Global In-Vivo Toxicology Market overview: By Toxicity Endpoints
- Chapter 8. Global In-Vivo Toxicology Market - Testing facility Analysis
- 8.1 Global In-Vivo Toxicology Market overview: By Testing facility
- 8.1.1 Global In-Vivo Toxicology Market share, By Testing facility, 2021 and 2028
- 8.2 Outsourced
- 8.2.1 Global In-Vivo Toxicology Market by Outsourced, 2022 - 2028 (USD Billion)
- 8.3 In-house
- 8.3.1 Global In-Vivo Toxicology Market by In-house, 2022 - 2028 (USD Billion)
- 8.1 Global In-Vivo Toxicology Market overview: By Testing facility
- Chapter 9. Global In-Vivo Toxicology Market - End-user Analysis
- 9.1 Global In-Vivo Toxicology Market overview: By End-user
- 9.1.1 Global In-Vivo Toxicology Market share, By End-user, 2021 and 2028
- 9.2 Academic Institutes
- 9.2.1 Global In-Vivo Toxicology Market by Academic Institutes, 2022 - 2028 (USD Billion)
- 9.3 Research Institutes
- 9.3.1 Global In-Vivo Toxicology Market by Research Institutes, 2022 - 2028 (USD Billion)
- 9.4 CRO’s
- 9.4.1 Global In-Vivo Toxicology Market by CRO’s, 2022 - 2028 (USD Billion)
- 9.1 Global In-Vivo Toxicology Market overview: By End-user
- Chapter 10. In-Vivo Toxicology Market - Regional Analysis
- 10.1 Global In-Vivo Toxicology Market Regional Overview
- 10.2 Global In-Vivo Toxicology Market Share, by Region, 2021 & 2028 (USD Billion)
- 10.3. North America
- 10.3.1 North America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.3.1.1 North America In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.3.1 North America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.4 North America In-Vivo Toxicology Market, by Product Type, 2022 - 2028
- 10.4.1 North America In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 North America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
- 10.5.1 North America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 North America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
- 10.6.1 North America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 North America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
- 10.7.1 North America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 North America In-Vivo Toxicology Market, by End-user, 2022 - 2028
- 10.8.1 North America In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.4. Europe
- 10.4.2 Europe In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.4.2.1 Europe In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.4.2 Europe In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.4 Europe In-Vivo Toxicology Market, by Product Type, 2022 - 2028
- 10.4.1 Europe In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 Europe In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
- 10.5.1 Europe In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 Europe In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
- 10.6.1 Europe In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 Europe In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
- 10.7.1 Europe In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 Europe In-Vivo Toxicology Market, by End-user, 2022 - 2028
- 10.8.1 Europe In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.5. Asia Pacific
- 10.5.3 Asia Pacific In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.5.3.1 Asia Pacific In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.5.3 Asia Pacific In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.4 Asia Pacific In-Vivo Toxicology Market, by Product Type, 2022 - 2028
- 10.4.1 Asia Pacific In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 Asia Pacific In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
- 10.5.1 Asia Pacific In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 Asia Pacific In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
- 10.6.1 Asia Pacific In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 Asia Pacific In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
- 10.7.1 Asia Pacific In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 Asia Pacific In-Vivo Toxicology Market, by End-user, 2022 - 2028
- 10.8.1 Asia Pacific In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.6. Latin America
- 10.6.4 Latin America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.6.4.1 Latin America In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.6.4 Latin America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.4 Latin America In-Vivo Toxicology Market, by Product Type, 2022 - 2028
- 10.4.1 Latin America In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 Latin America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
- 10.5.1 Latin America In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 Latin America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
- 10.6.1 Latin America In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 Latin America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
- 10.7.1 Latin America In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 Latin America In-Vivo Toxicology Market, by End-user, 2022 - 2028
- 10.8.1 Latin America In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- 10.7. The Middle-East and Africa
- 10.7.5 The Middle-East and Africa In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.7.5.1 The Middle-East and Africa In-Vivo Toxicology Market, by Country, 2022 - 2028 (USD Billion)
- 10.7.5 The Middle-East and Africa In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 10.4 The Middle-East and Africa In-Vivo Toxicology Market, by Product Type, 2022 - 2028
- 10.4.1 The Middle-East and Africa In-Vivo Toxicology Market, by Product Type, 2022 - 2028 (USD Billion)
- 10.5 The Middle-East and Africa In-Vivo Toxicology Market, by Testing Types, 2022 - 2028
- 10.5.1 The Middle-East and Africa In-Vivo Toxicology Market, by Testing Types, 2022 - 2028 (USD Billion)
- 10.6 The Middle-East and Africa In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028
- 10.6.1 The Middle-East and Africa In-Vivo Toxicology Market, by Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 10.7 The Middle-East and Africa In-Vivo Toxicology Market, by Testing facility, 2022 - 2028
- 10.7.1 The Middle-East and Africa In-Vivo Toxicology Market, by Testing facility, 2022 - 2028 (USD Billion)
- 10.8 The Middle-East and Africa In-Vivo Toxicology Market, by End-user, 2022 - 2028
- 10.8.1 The Middle-East and Africa In-Vivo Toxicology Market, by End-user, 2022 - 2028 (USD Billion)
- Chapter 11. Company Profiles
- 11.1 Charles River Laboratories
- 11.1.1 Overview
- 11.1.2 Financials
- 11.1.3 Product Portfolio
- 11.1.4 Business Strategy
- 11.1.5 Recent Developments
- 11.2 The Jackson Laboratory
- 11.2.1 Overview
- 11.2.2 Financials
- 11.2.3 Product Portfolio
- 11.2.4 Business Strategy
- 11.2.5 Recent Developments
- 11.3 Envigo
- 11.3.1 Overview
- 11.3.2 Financials
- 11.3.3 Product Portfolio
- 11.3.4 Business Strategy
- 11.3.5 Recent Developments
- 11.4 Taconic Biosciences
- 11.4.1 Overview
- 11.4.2 Financials
- 11.4.3 Product Portfolio
- 11.4.4 Business Strategy
- 11.4.5 Recent Developments
- 11.5 Janvier Labs
- 11.5.1 Overview
- 11.5.2 Financials
- 11.5.3 Product Portfolio
- 11.5.4 Business Strategy
- 11.5.5 Recent Developments
- 11.6 Thermo Fisher Scientific
- 11.6.1 Overview
- 11.6.2 Financials
- 11.6.3 Product Portfolio
- 11.6.4 Business Strategy
- 11.6.5 Recent Developments
- 11.7 Danaher Corporation
- 11.7.1 Overview
- 11.7.2 Financials
- 11.7.3 Product Portfolio
- 11.7.4 Business Strategy
- 11.7.5 Recent Developments
- 11.8 Waters Corporation
- 11.8.1 Overview
- 11.8.2 Financials
- 11.8.3 Product Portfolio
- 11.8.4 Business Strategy
- 11.8.5 Recent Developments
- 11.9 Agilent Technologies
- 11.9.1 Overview
- 11.9.2 Financials
- 11.9.3 Product Portfolio
- 11.9.4 Business Strategy
- 11.9.5 Recent Developments
- 11.10 Shimadzu Corporation
- 11.10.1 Overview
- 11.10.2 Financials
- 11.10.3 Product Portfolio
- 11.10.4 Business Strategy
- 11.10.5 Recent Developments
- 11.11 Bruker Corporation
- 11.11.1 Overview
- 11.11.2 Financials
- 11.11.3 Product Portfolio
- 11.11.4 Business Strategy
- 11.11.5 Recent Developments
- 11.12 PerkinElmer
- 11.12.1 Overview
- 11.12.2 Financials
- 11.12.3 Product Portfolio
- 11.12.4 Business Strategy
- 11.12.5 Recent Developments
- 11.13 MerckkgaA
- 11.13.1 Overview
- 11.13.2 Financials
- 11.13.3 Product Portfolio
- 11.13.4 Business Strategy
- 11.13.5 Recent Developments
- 11.14 GE Healthcare
- 11.14.1 Overview
- 11.14.2 Financials
- 11.14.3 Product Portfolio
- 11.14.4 Business Strategy
- 11.14.5 Recent Developments
- 11.15 Bio-Rad laboratories
- 11.15.1 Overview
- 11.15.2 Financials
- 11.15.3 Product Portfolio
- 11.15.4 Business Strategy
- 11.15.5 Recent Developments
- 11.16 genOway
- 11.16.1 Overview
- 11.16.2 Financials
- 11.16.3 Product Portfolio
- 11.16.4 Business Strategy
- 11.16.5 Recent Developments
- 11.17 Cyagen Biosciences
- 11.17.1 Overview
- 11.17.2 Financials
- 11.17.3 Product Portfolio
- 11.17.4 Business Strategy
- 11.17.5 Recent Developments
- 11.18 GVK BIO
- 11.18.1 Overview
- 11.18.2 Financials
- 11.18.3 Product Portfolio
- 11.18.4 Business Strategy
- 11.18.5 Recent Developments
- 11.19 Polygene
- 11.19.1 Overview
- 11.19.2 Financials
- 11.19.3 Product Portfolio
- 11.19.4 Business Strategy
- 11.19.5 Recent Developments
- 11.20 Crown Biosciences
- 11.20.1 Overview
- 11.20.2 Financials
- 11.20.3 Product Portfolio
- 11.20.4 Business Strategy
- 11.20.5 Recent Developments
- 11.21 Transcure Bioservices
- 11.21.1 Overview
- 11.21.2 Financials
- 11.21.3 Product Portfolio
- 11.21.4 Business Strategy
- 11.21.5 Recent Developments
- 11.22 Harbour BioMed.
- 11.22.1 Overview
- 11.22.2 Financials
- 11.22.3 Product Portfolio
- 11.22.4 Business Strategy
- 11.22.5 Recent Developments
- 11.1 Charles River Laboratories
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global In-Vivo Toxicology Market attractiveness, By Product Type
- 6. Global In-Vivo Toxicology Market attractiveness, By Testing Types
- 7. Global In-Vivo Toxicology Market attractiveness, By Toxicity Endpoints
- 8. Global In-Vivo Toxicology Market attractiveness, By Testing facility
- 9. Global In-Vivo Toxicology Market attractiveness, By End-user
- 10. Global In-Vivo Toxicology Market share by Product Type, 2022 and 2028 (USD Billion)
- 11. Global In-Vivo Toxicology Market by Instruments, 2022 - 2028 (USD Billion)
- 12. Global In-Vivo Toxicology Market by Animal Models, 2022 - 2028 (USD Billion)
- 13. Global In-Vivo Toxicology Market by Reagents & Kits, 2022 - 2028 (USD Billion)
- 14. Global In-Vivo Toxicology Market share by Testing Types, 2022 and 2028 (USD Billion)
- 15. Global In-Vivo Toxicology Market by Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
- 16. Global In-Vivo Toxicology Market by Sub-Chronic Toxicity Testing, 2022 - 2028 (USD Billion)
- 17. Global In-Vivo Toxicology Market by Sub-acute Toxicity Testing, 2022 - 2028 (USD Billion)
- 18. Global In-Vivo Toxicology Market by Acute Toxicity Testing, 2022 - 2028 (USD Billion)
- 19. Global In-Vivo Toxicology Market share by Toxicity Endpoints, 2022 and 2028 (USD Billion)
- 20. Global In-Vivo Toxicology Market by Immunotoxicity, 2022 - 2028 (USD Billion)
- 21. Global In-Vivo Toxicology Market by Systemic, 2022 - 2028 (USD Billion)
- 22. Global In-Vivo Toxicology Market share by Testing facility, 2022 and 2028 (USD Billion)
- 23. Global In-Vivo Toxicology Market by Outsourced, 2022 - 2028 (USD Billion)
- 24. Global In-Vivo Toxicology Market by In-house, 2022 - 2028 (USD Billion)
- 25. Global In-Vivo Toxicology Market share by End-user, 2022 and 2028 (USD Billion)
- 26. Global In-Vivo Toxicology Market by Academic Institutes, 2022 - 2028 (USD Billion)
- 27. Global In-Vivo Toxicology Market by Research Institutes, 2022 - 2028 (USD Billion)
- 28. Global In-Vivo Toxicology Market by CRO’s, 2022 - 2028 (USD Billion)
- 29. Global In-Vivo Toxicology Market share, by Region, 2022 and 2028
- 30. North America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 31. Europe In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 32. Asia Pacific In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 33. Latin America In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
- 34. The Middle-East and Africa In-Vivo Toxicology Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global In-Vivo Toxicology Market: Snapshot
- 2. Drivers of the In-Vivo Toxicology Market: impact analysis
- 3. North America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 4. North America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 5. North America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 6. North America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 7. North America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 8. U.S. In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 9. U.S. In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 10. U.S. In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 11. U.S. In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 12. U.S. In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 13. Canada In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 14. Canada In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 15. Canada In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 16. Canada In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 17. Canada In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 18. Europe In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 19. Europe In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 20. Europe In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 21. Europe In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 22. Europe In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 23. Germany In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 24. Germany In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 25. Germany In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 26. Germany In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 27. Germany In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 28. France In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 29. France In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 30. France In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 31. France In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 32. France In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 33. U.K. In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 34. U.K. In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 35. U.K. In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 36. U.K. In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 37. U.K. In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 38. Italy In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 39. Italy In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 40. Italy In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 41. Italy In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 42. Italy In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 43. Spain In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 44. Spain In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 45. Spain In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 46. Spain In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 47. Spain In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 48. Rest of Europe In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 49. Rest of Europe In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 50. Rest of Europe In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 51. Rest of Europe In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 52. Rest of Europe In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 53. Asia Pacific In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 54. Asia Pacific In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 55. Asia Pacific In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 56. Asia Pacific In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 57. Asia Pacific In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 58. China In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 59. China In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 60. China In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 61. China In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 62. China In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 63. Japan In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 64. Japan In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 65. Japan In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 66. Japan In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 67. Japan In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 68. India In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 69. India In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 70. India In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 71. India In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 72. India In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 73. South Korea In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 74. South Korea In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 75. South Korea In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 76. South Korea In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 77. South Korea In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 78. South-East Asia In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 79. South-East Asia In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 80. South-East Asia In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 81. South-East Asia In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 82. South-East Asia In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 83. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 84. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 85. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 86. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 87. Rest of Asia Pacific In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 88. Latin America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 89. Latin America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 90. Latin America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 91. Latin America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 92. Latin America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 93. Brazil In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 94. Brazil In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 95. Brazil In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 96. Brazil In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 97. Brazil In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 98. Mexico In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 99. Mexico In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 100. Mexico In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 101. Mexico In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 102. Mexico In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 103. Rest of Latin America In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 104. Rest of Latin America In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 105. Rest of Latin America In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 106. Rest of Latin America In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 107. Rest of Latin America In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 108. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 109. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 110. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 111. The Middle-East and Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 112. The Middle-East and Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 113. GCC Countries In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 114. GCC Countries In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 115. GCC Countries In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 116. GCC Countries In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 117. GCC Countries In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 118. South Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 119. South Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 120. South Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 121. South Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 122. South Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
- 123. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Product Type, 2022 - 2028 (USD Billion)
- 124. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Testing Types, 2022 - 2028 (USD Billion)
- 125. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Toxicity Endpoints, 2022 - 2028 (USD Billion)
- 126. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By Testing facility, 2022 - 2028 (USD Billion)
- 127. Rest of Middle-East Africa In-Vivo Toxicology Market revenue, By End-user, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
The Global in-vivo toxicology market is expected to grow due to rising focus on drug safety, increasing regulatory requirements, and demand for preclinical testing.
According to a study, the Global in-vivo toxicology market size was worth around USD 4.89 Billion in 2024 and is expected to reach USD 8.48 Billion by 2034.
The Global in-vivo toxicology market is expected to grow at a CAGR of 5.8% during the forecast period.
North America is expected to dominate the in-vivo toxicology market over the forecast period.
Leading players in the Global in-vivo toxicology market include Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Janvier Labs, Thermo Fisher Scientific, Danaher Corporation, Waters Corporation, Agilent Technologies, Shimadzu Corporation, Bruker Corporation, PerkinElmer, MerckkgaA, GE Healthcare, Bio-Rad laboratories, genOway, Cyagen Biosciences, GVK BIO, Polygene, Crown Biosciences, Transcure Bioservices, Harbour BioMed.,, among others.
The report explores crucial aspects of the in-vivo toxicology market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
